 "Divi's Labs gains 4% on successful USFDA inspection of Telangana unit")
Shares of Divi’s Laboratories were up 4% at Rs 1,213 per share on the BSE in early morning trade after the drug firm said that the inspection conducted by the US health regulator of its Unit-1 facility at Choutuppal, Telangana this month was successful. The stock was trading close to its 52-week high of Rs 1,220 touched on May 11, 2018 in intra-day trade.
“Unit-I at Choutuppal, Telangana state has had an inspection by the United States Food and Drug Administration (US-FDA) from 14th May 2018 to 16th May, 2018. This was a general cGMP inspection by the FDA. The inspection has been concluded with no 483 observations,” Divi’s Labs said in a BSE filing.
At 09:27 am; the stock was trading 3% higher at Rs 1,199 on the BSE, as compared to 0.12% rise in the S&P BSE Sensex. A combined 264,718 shares changed hands on the counter on the BSE and NSE so far.
“Unit-I at Choutuppal, Telangana state has had an inspection by the United States Food and Drug Administration (US-FDA) from 14th May 2018 to 16th May, 2018. This was a general cGMP inspection by the FDA. The inspection has been concluded with no 483 observations,” Divi’s Labs said in a BSE filing.
At 09:27 am; the stock was trading 3% higher at Rs 1,199 on the BSE, as compared to 0.12% rise in the S&P BSE Sensex. A combined 264,718 shares changed hands on the counter on the BSE and NSE so far.
One subscription. Two world-class reads.
Already subscribed? Log in
Subscribe to read the full story →*Subscribe to Business Standard digital and get complimentary access to The New York Times
Smart Quarterly
₹900
3 Months
₹300/Month
SAVE 25%
Smart Essential
₹2,700
1 Year
₹225/Month
SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months
Super Saver
₹3,900
2 Years
₹162/Month
Subscribe
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
SAVE 25%